Erschienen in:
14.07.2023 | Images in Hematology
Rivaroxaban for severe superior sagittal sinus thrombosis in a child with ALL
verfasst von:
Masaki Yamamoto, Yusuke Akane, Ryo Hamada, Hiroyuki Kabutoya, Keita Igarashi, Sangnyon Kim, Takeshi Tsugawa
Erschienen in:
International Journal of Hematology
|
Ausgabe 3/2023
Einloggen, um Zugang zu erhalten
Excerpt
It is well known that thrombotic events can occur during induction chemotherapy for acute lymphoblastic leukemia (ALL). Cerebral sinus venous thrombosis has a cumulative incidence of 1.4% and mortality of 8.7% in children with ALL [
1]. Here, we report a case of severe superior sagittal sinus (SSS) thrombosis and intracranial hemorrhage associated with induction chemotherapy for ALL, in which we used rivaroxaban, a direct oral anticoagulant, to prevent exacerbation of venous thrombosis during treatment. …